Andrographolide, a new potential NF-κB inhibitor: Docking simulation and evaluation of drug-likeness

Molecular Simulation

Volumn 38, Issue 7, 2012, Pages 582-588

  Raghavan, Rahul ^a   Cheriyamundath, Sanith ^a   Madassery, Joseph ^a  

^a UNIVERSITY OF CALICUT   (India)

Author keywords

andrographolide; ArgusLab 4.0.1; docking; glutathione S transferase; NF B p50 inhibitor

Indexed keywords

ACTIVE SITE; ANDROGRAPHOLIDE; ANTI-INFLAMMATORY AGENTS; ARGUSLAB 4.0.1; CANCER CELL LINES; CLINICAL TRIAL; CYTOTOXIC; DOCKING SIMULATIONS; DRUG SCORE; FURAN RING; GLUTATHIONE-S-TRANSFERASE; IN-VITRO; LYMPHOMA CELLS; REDUCED GLUTATHIONE; TARGET PROTEINS;

AMINO ACIDS; BIOCHEMISTRY; CELL CULTURE; CELL DEATH; ENZYMES; MOLECULES; PEPTIDES;

DOCKING;

EID: 84862106965     PISSN: 08927022     EISSN: 10290435     Source Type: Journal    
DOI: 10.1080/08927022.2011.651138     Document Type: Article

References (33)

1. A. Varma, H. Padh, and N. Shrivastava, Andrographolide: A new plant-derived antineoplastic entity on horizon, Evid. Based Compl. Alt. Med. 2011 (2011), p. 9.
2. Herba Andrographidis, WHO monograph for medicinal plant 2, (2004), pp. 12-24. Available at http://apps.who.int/medicinedocs/en/d/Js4927e/
3. Y.J. Wang, J.T. Wang, Q.X. Fan, and J.G. Geng, Andrographolide inhibits NF-kappaBeta activation and attenuates neointimal hyperplasia in arterial restenosis, Cell Res. 17 (2007), pp. 933-941.
4. M.A. Hidalgo, A. Romero, J. Fiqueroa, P. Cortes, II. Concha, J.L. Hancke, and R.A. Burqos, Andrographolide interferes with binding of nuclear factor-kappaB to DNA in HL-60-derived neutrophilic cells, Br. J. Pharmacol. 144 (2005), pp. 680-686.
5. Y.F. Xia, B.Q. Ye, J.G. Wang, X.J. He, X. Lin, X. Yao, D. Ma, A. Slungaard, R.P. Hebbel, N.S. Key, and J.G. Geng, Andrographolide attenuates inflammation by inhibition of NF-kappa B activation through covalent modification of reduced cysteine 62 of p50, J. Immunol. 173 (2004), pp. 4207-4217.
6. B.B. Aggarwal, G. Sethi, and A. Nair, Nuclear factor-B: A holy grail in cancer prevention and therapy, Curr. Sig. Trans. Therapy 1 (2006), pp. 25-52.
7. M. Venkatraman, R.J. Anto, A. Nair, M. Varghese, and D. Karunagaran, Biological and chemical inhibitors of NF-kB sensitize SiHa cells to cisplatin-induced apoptosis, Mol. Carcinogen. 44 (2005), pp. 51-59.
8. A. Arlt, A. Gehrz, S. Muerkoster, J. Vorndamm, M.L. Kruse, U.R. Folsch, and H. Schafer, Role of NF-[kappa]B and Akt//PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death, Oncogene 22 (2003), pp. 3243-3251.
9. J.C. Hermann, R. Marti-Arbona, A.A. Fedorov, E. Fedorov, S.C. Almo, B.K. Shoichat, and F.M. Raushel, Structure-based activity prediction for an enzyme of unknown function, Nature 448 (2007), pp. 755-759.
10. S.L. Lin, D. Xu, M. Rosen, A. Li, M. Rosen, H.J. Wolfson, and R. Nussinov, Investigation of the enzymatic mechanism of the yeast chorismate mutase by docking a transition state analog, J. Mol. Biol. 271 (1997), pp. 838-845.
11. S. Mondal and K. Mizuguchi, Structural insight into the mechanism of a new family of D-2-hydroxyacid dehydrogenases, a close homolog of 2-ketopantoate reductase, Genome Inform. Ser. 23 (2009), pp. 98-105.
12. S. Yang, A.M. Evens, S. Prachand, A.T. Singh, S. Bhalla, K. David, and L.I. Gordon, Mitochondrial-mediated apoptosis in lymphoma cells by the diterpenoid lactone andrographolide, the active component of Andrographis paniculata, Clin. Cancer Res. 16 (2010), pp. 4755-4768.
13. Z. Zhiqiang, C.K. Gallant, L. Jieliang, F. Wang-Fun, and C. Hon-Young, Molecular interaction between andrographolide and glutathione follows second order kinetics, Chem. Pharm. Bull. 56 (2008), pp. 1229-1233.
14. C. D'Silva, Inhibition and recognition studies on the glutathionebinding site of equine liver glutathione S-transferase, Biochem. J. 271 (1990), pp. 161-165.
15. D.M. Townsend and K.D. Tew, The role of glutathione- S-transferase in anti-cancer drug resistance, Oncogene 22 (2003), pp. 7369-7375.
16. S. Gisbert, Prediction of Drug-Like Properties, Madame Curie Bioscience Database, Book shelf ID: NBK6404, NCBI, (2000). Available at http://www.ncbi.nlm.nih.gov/books/NBK6404
17. C.A. Lipinski, F. Lombardo, B.W. Dominy, and P.J. Feeney, Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings, Adv. Drug Delivery Rev. 46 (2001), pp. 3-26.
18. OSIRIS property explorer, Allschwil, Switzerland. Available at http://www.organic-chemistry.org/prog/peo/
19. Moleinspiration, Slovensky Grob, Slovak Republic, Available at http://www.molinspiration.com/cgi-bin/properties
20. A. Leo, P.Y. Jow, C. Silipo, and C. Hansch, Calculation of hydrophobic constant (log P) from pi and f constants, J. Med. Chem. 18 (1975), pp. 865-868.
21. U. Norinder, P. Sjoberg, and T. Osterberg, Theoretical calculation and prediction of brain-blood partitioning of organic solutes using MolSurf parametrization and PLS statistics, J. Pharm. Sci. 87 (1998), pp. 952-959.
22. M. Feher, E. Sourial, and M. Schmidt, A simple model for the prediction of blood-brain partitioning, Int. J. Pharm. 201 (2000), pp. 239-247.
23. J. Huuskonen, M. Salo, and J. Taskinen, Aqueous solubility prediction of drugs based on molecular topology and neural network modeling, J. Chem. Inf. Comput. Sci. 38 (1998), pp. 450-456.
24. D.S. Dalafave and G. Prisco, Inhibition of antiapoptotic BCL-XL, BCL-2, and MCL- 1 proteins by small molecule mimetics, Cancer Inform. 9 (2010), pp. 169-177.
25. T.A. Sangamwar, U.D. Deshpande, S.S. Pekamwar, and M.S. Vadavalkar, Improving decision making for drug candidates - a computational approach for benzthiazoles as ANTIFUNGAL, Indian J. Biotechnol. 6 (2007), pp. 389-396.
26. Ramachandran plot for 1NFK structure from EMBL-EBI database - PROCHEK. Available at http://www.ebi.ac.uk/thornton-srv/databa ses/cgi-bin/pdbsum/ GetPage.pl?pdbcode=1nfk&template=pro check-summary.html
27. G. Gourisankar, V.D. Gregory, G. Sankar, and S.B. Paul, Structure of NF-kB p50 homodimer bound to a kB site, Nature 373 (1995), pp. 303-310.
28. Ramachandran plot for 3RPN structure from EMBL-EBI database - PROCHEK. Available at http://www.ebi.ac.uk/thornton-srv/databa ses/cgi-bin/pdbsum/ GetPage.pl?pdbcode=3rpn&template=pro check-summary.html
29. M.A. Thompson, ArgusLAb 4.0.1, Thompson, Planaria software LLC, Seattle, WA. Available at http://www.arguslab.com/.
30. M.L. Mihojlovic and p.M. Mitrasinovic, Application of the ArgusLab 4/A score protocol in the structure-based binding prediction of various inhibitors of group-1 and group-2 influenza virus neuraminidazes, Mol. Simulat. 35 (2009), pp. 311-324.
31. K. Nikolic, S. Filipic, and D. Agbaba, QSAR study of imidazoline antihypertensive drugs, Bioorg. Med. Chem. 16 (2008), pp. 7134-7140.
32. M. Yang, L. Zhou, Z. Zuo, X. Tang, J. Liu, and X. Ma, Structurebased virtual screening for glycosyltransferase, Mol. Simulat. 34 (2008), pp. 849-856.
33. J. Hupfeld and T. Efferth, Drug resistance of human immunodeficiency virus and overcoming it by natural products, Invivo 23 (2009), pp. 1-6.